Insider Transactions in Q3 2021 at Biolife Solutions Inc (BLFS)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
505
-0.64%
|
$21,715
$43.12 P/Share
|
|
Sep 28
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
689
-0.54%
|
$29,627
$43.12 P/Share
|
|
Sep 28
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
907
-0.34%
|
$39,001
$43.12 P/Share
|
|
Sep 28
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
610
-0.84%
|
$26,230
$43.12 P/Share
|
|
Sep 28
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
719
-0.34%
|
$30,917
$43.12 P/Share
|
|
Sep 27
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
16,332
-18.4%
|
$718,608
$44.66 P/Share
|
|
Sep 27
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,332
+15.54%
|
$16,332
$1.64 P/Share
|
|
Sep 22
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.56%
|
$460,000
$46.99 P/Share
|
|
Sep 22
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.36%
|
$10,000
$1.64 P/Share
|
|
Sep 20
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.56%
|
$460,000
$46.89 P/Share
|
|
Sep 20
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.36%
|
$10,000
$1.64 P/Share
|
|
Sep 16
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.23%
|
$283,360
$46.1 P/Share
|
|
Sep 16
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.74%
|
$6,160
$1.64 P/Share
|
|
Sep 15
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.23%
|
$301,840
$49.01 P/Share
|
|
Sep 15
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.74%
|
$6,160
$1.64 P/Share
|
|
Sep 09
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.14%
|
$595,972
$52.59 P/Share
|
|
Sep 09
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+3.97%
|
$11,461
$1.64 P/Share
|
|
Sep 07
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.14%
|
$595,972
$52.5 P/Share
|
|
Sep 07
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+3.97%
|
$11,461
$1.64 P/Share
|
|
Sep 01
2021
|
Casdin Partners Master Fund, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
126,185
+1.64%
|
-
|
|
Aug 27
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
399
-0.19%
|
$22,743
$57.26 P/Share
|
|
Aug 26
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
848
-0.32%
|
$48,336
$57.26 P/Share
|
|
Aug 26
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
325
-0.45%
|
$18,525
$57.26 P/Share
|
|
Aug 25
2021
|
Joseph C Schick Director |
SELL
Open market or private sale
|
Direct |
1,875
-13.64%
|
$97,500
$52.54 P/Share
|
|
Aug 25
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.55%
|
$530,000
$53.12 P/Share
|
|
Aug 25
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.36%
|
$10,000
$1.64 P/Share
|
|
Aug 23
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
16,332
-18.33%
|
$751,272
$46.54 P/Share
|
|
Aug 23
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,332
+15.49%
|
$16,332
$1.64 P/Share
|
|
Aug 23
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.55%
|
$460,000
$46.54 P/Share
|
|
Aug 23
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.36%
|
$10,000
$1.64 P/Share
|
|
Aug 19
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
12,000
-8.53%
|
$540,000
$45.12 P/Share
|
|
Aug 18
2021
|
Joseph C Schick Director |
SELL
Open market or private sale
|
Direct |
625
-4.35%
|
$27,500
$44.11 P/Share
|
|
Aug 18
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
22,239
-7.08%
|
$978,516
$44.7 P/Share
|
|
Aug 17
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
12,000
-6.86%
|
$528,000
$44.81 P/Share
|
|
Aug 17
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.23%
|
$271,040
$44.8 P/Share
|
|
Aug 17
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.74%
|
$6,160
$1.64 P/Share
|
|
Aug 16
2021
|
Andrew G Hinson Director |
SELL
Open market or private sale
|
Direct |
2,500
-12.39%
|
$110,000
$44.51 P/Share
|
|
Aug 16
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.23%
|
$283,360
$46.03 P/Share
|
|
Aug 16
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.74%
|
$6,160
$1.64 P/Share
|
|
Aug 05
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.13%
|
$550,128
$48.37 P/Share
|
|
Aug 05
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+3.96%
|
$11,461
$1.64 P/Share
|
|
Aug 03
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.13%
|
$550,128
$48.26 P/Share
|
|
Aug 03
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+3.96%
|
$11,461
$1.64 P/Share
|
|
Jul 29
2021
|
Michael Rice |
SELL
Bona fide gift
|
Direct |
3,000
-1.11%
|
-
|
|
Jul 26
2021
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
4,919
-6.88%
|
$226,274
$46.13 P/Share
|
|
Jul 26
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
16,333
-18.33%
|
$734,985
$45.24 P/Share
|
|
Jul 26
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,333
+15.49%
|
$16,333
$1.64 P/Share
|
|
Jul 21
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,854
-4.05%
|
$398,430
$45.61 P/Share
|
|
Jul 21
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,854
+3.9%
|
$8,854
$1.64 P/Share
|
|
Jul 20
2021
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,059
-5.07%
|
$47,655
$45.1 P/Share
|